The store will not work correctly when cookies are disabled.
1-(5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl)-3-(methylsulfonyl)imidazolidin-2-one
ID: ALA5208874
PubChem CID: 168294393
Max Phase: Preclinical
Molecular Formula: C12H11FN4O4S
Molecular Weight: 326.31
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CS(=O)(=O)N1CCN(c2nnc(-c3ccc(F)cc3)o2)C1=O
Standard InChI: InChI=1S/C12H11FN4O4S/c1-22(19,20)17-7-6-16(12(17)18)11-15-14-10(21-11)8-2-4-9(13)5-3-8/h2-5H,6-7H2,1H3
Standard InChI Key: UWPSHDHGUSROMV-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
-0.2687 -0.4388 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.9362 0.0460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6812 0.8308 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.1438 0.8308 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3986 0.0460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1958 -0.1674 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.8368 0.3514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5287 -0.0976 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.3151 -0.8944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4913 -0.9375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7333 -0.1674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9472 -0.9646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7421 -1.1768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3259 -0.5930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1148 0.2003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3193 0.4184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8368 1.1768 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.3258 0.1159 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
3.5394 0.9130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5398 -0.6826 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.1229 -0.0976 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.1229 -0.8067 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 1 1 0
6 5 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 6 1 0
11 2 1 0
12 11 2 0
13 12 1 0
14 13 2 0
15 14 1 0
11 16 1 0
16 15 2 0
7 17 2 0
8 18 1 0
18 19 1 0
18 20 2 0
18 21 2 0
14 22 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 326.31 | Molecular Weight (Monoisotopic): 326.0485 | AlogP: 1.08 | #Rotatable Bonds: 3 |
Polar Surface Area: 96.61 | Molecular Species: NEUTRAL | HBA: 6 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 0.11 | CX LogD: 0.11 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.84 | Np Likeness Score: -1.79 |
References
1. De S, Aamna B, Sahu R, Parida S, Behera SK, Dan AK.. (2022) Seeking heterocyclic scaffolds as antivirals against dengue virus., 240 [PMID:35816877] [10.1016/j.ejmech.2022.114576] |